Trial Profile
A randomised, single-blind bridging study evaluating the immunogenicity and safety of an inactivated trivalent influenza HA vaccine [FluBio] in adolescents and adults
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 16 May 2014
Price :
$35
*
At a glance
- Drugs Influenza HA vaccine (Flubio) (Primary)
- Indications Influenza A virus H1N1 subtype; Influenza A virus H3N2 subtype; Influenza B virus infections
- Focus Adverse reactions; Pharmacodynamics
- 16 May 2014 New trial record